MedPath

Colazal

These highlights do not include all the information needed to use COLAZAL safely and effectively. See full prescribing information for COLAZAL. COLAZAL® (balsalazide disodium) capsules, for oral use Initial U.S. Approval: 2000

Approved
Approval ID

22f41e83-b9fb-4c9e-8cc3-f457034191a8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 2, 2023

Manufacturers
FDA

Salix Pharmaceuticals, Inc

DUNS: 793108036

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

balsalazide disodium

PRODUCT DETAILS

NDC Product Code65649-101
Application NumberNDA020610
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateNovember 2, 2023
Generic Namebalsalazide disodium

INGREDIENTS (3)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
BALSALAZIDE DISODIUMActive
Quantity: 750 mg in 1 1
Code: 1XL6BJI034
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Colazal - FDA Drug Approval Details